Tags

Type your tag names separated by a space and hit enter

Herbal medicines: challenges in the modern world. Part 3. China and Japan.
Expert Rev Clin Pharmacol 2016; 9(9):1225-33ER

Abstract

INTRODUCTION

Medicinal plants, and formulations prepared from them, have been used in China and Japan for thousands of years. Nowadays, ancient formulations of Traditional Chinese and Kampo (Japanese) Medicines coexist with Western herbal medicines (HMs) and complement each other. HMs are used for the treatment of mild and chronic diseases, as an adjunct therapy, to improve wellbeing and delay aging, or as healthy (functional) foods.

AREAS COVERED

This article, a third part in a series of reviews, is focusing on history, use and regulation of the traditional and modern HMs in Japan and China. Materials available from legislative and governmental websites, PubMed and news media were used. Expert commentary: HMs are heavily regulated in both countries, often in a similar manner as conventional pharmaceutical drugs. The majority of herbal formulations are sold as over-the-counter medications supplied with leaflets describing indications and appropriate dosages for patients of different ages. Medical practitioners prescribe herbal formulations that are tailored to the needs of particular patients. Both countries had problems with adverse drug reactions and toxicity of single herbs and herbal formulations that have been investigated by authorities, and some drugs have been removed from the market.

Authors+Show Affiliations

a Department of Drug Policy & Management, Graduate School of Pharmaceutical Sciences , The University of Tokyo , Tokyo , Japan.b School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China. c Jiangsu Engineering Research Center for Efficient Delivery System of Traditional Chinese Medicine , Nanjing , China. d Nanjing Engineering Research Center for Industrialization Traditional Chinese Medicine Pellets , Nanjing , China.e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA.e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA.e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA.f Division of Pharmaceutical Sciences, School of Pharmacy , University of Missouri-Kansas City , Kansas City , MI , USA.b School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China. c Jiangsu Engineering Research Center for Efficient Delivery System of Traditional Chinese Medicine , Nanjing , China. d Nanjing Engineering Research Center for Industrialization Traditional Chinese Medicine Pellets , Nanjing , China.e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA. g Department of Pharmacology and Toxicology , University of Utah , Salt Lake City , UT , USA.e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA. h Division of Microbiology and Immunology, the Department of Pathology , University of Utah School of Medicine , Salt Lake City , UT , USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

27232545

Citation

Teng, Lida, et al. "Herbal Medicines: Challenges in the Modern World. Part 3. China and Japan." Expert Review of Clinical Pharmacology, vol. 9, no. 9, 2016, pp. 1225-33.
Teng L, Zu Q, Li G, et al. Herbal medicines: challenges in the modern world. Part 3. China and Japan. Expert Rev Clin Pharmacol. 2016;9(9):1225-33.
Teng, L., Zu, Q., Li, G., Yu, T., Job, K. M., Yang, X., ... Enioutina, E. Y. (2016). Herbal medicines: challenges in the modern world. Part 3. China and Japan. Expert Review of Clinical Pharmacology, 9(9), pp. 1225-33. doi:10.1080/17512433.2016.1195263.
Teng L, et al. Herbal Medicines: Challenges in the Modern World. Part 3. China and Japan. Expert Rev Clin Pharmacol. 2016;9(9):1225-33. PubMed PMID: 27232545.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Herbal medicines: challenges in the modern world. Part 3. China and Japan. AU - Teng,Lida, AU - Zu,Qiang, AU - Li,Gangzhou, AU - Yu,Tian, AU - Job,Kathleen M, AU - Yang,Xiaoyan, AU - Di,Liuqing, AU - Sherwin,Catherine Mt, AU - Enioutina,Elena Y, Y1 - 2016/06/08/ PY - 2016/5/28/entrez PY - 2016/5/28/pubmed PY - 2017/3/11/medline KW - Kampo medicine KW - Yin and Yang balance KW - five elements KW - five flavors KW - four natures KW - herbal medicines KW - meridians KW - regulations KW - safety KW - traditional Chinese medicine SP - 1225 EP - 33 JF - Expert review of clinical pharmacology JO - Expert Rev Clin Pharmacol VL - 9 IS - 9 N2 - INTRODUCTION: Medicinal plants, and formulations prepared from them, have been used in China and Japan for thousands of years. Nowadays, ancient formulations of Traditional Chinese and Kampo (Japanese) Medicines coexist with Western herbal medicines (HMs) and complement each other. HMs are used for the treatment of mild and chronic diseases, as an adjunct therapy, to improve wellbeing and delay aging, or as healthy (functional) foods. AREAS COVERED: This article, a third part in a series of reviews, is focusing on history, use and regulation of the traditional and modern HMs in Japan and China. Materials available from legislative and governmental websites, PubMed and news media were used. Expert commentary: HMs are heavily regulated in both countries, often in a similar manner as conventional pharmaceutical drugs. The majority of herbal formulations are sold as over-the-counter medications supplied with leaflets describing indications and appropriate dosages for patients of different ages. Medical practitioners prescribe herbal formulations that are tailored to the needs of particular patients. Both countries had problems with adverse drug reactions and toxicity of single herbs and herbal formulations that have been investigated by authorities, and some drugs have been removed from the market. SN - 1751-2441 UR - https://www.unboundmedicine.com/medline/citation/27232545/Herbal_medicines:_challenges_in_the_modern_world__Part_3__China_and_Japan_ L2 - http://www.tandfonline.com/doi/full/10.1080/17512433.2016.1195263 DB - PRIME DP - Unbound Medicine ER -